Convatec: Well Postioned for Acceleration Beyond 2026
Convatec is a global manufacturer of intimate healthcare products, with a focus on ostomy, continence care, wound care, and infusion care.
Convatec Group PLC CTEC
Bulls Say, Bears Say
Bulls
Significant headroom for further operational efficiency improvements makes it likely that Convatec extends its four-year track record of margin expansion.
Bears
Ostomy patients are highly brand loyal, meaning market share recovery is likely to be a slow and gradual process.
News
-
Convatec Recognized With Two Prestigious Vizient® Supplier Excellence Awards
-
Convatec Survey Challenges Assumptions About Leakage in Ostomy Care
-
Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize
-
Novo Nordisk Owner Sells Convatec Stake for $462 Million
-
Novo Nordisk Owner to Sell Convatec Stake
Trading Information
- Previous Close Price
- GBX244.00
- Day Range
- GBX242.00–246.20
- 52-Week Range
- GBX193.00–259.30
- Bid/Ask
- GBX179.00 / GBX260.00
- Shares Outstanding
- 1.91B
- Market Cap
- GBX470.69B
- Volume/Avg
- 5M / 8M
Key Statistics
- Price/Earnings (Normalized)
- 25.34
- Price/Sales
- 2.64
- Dividend Yield (Trailing)
- 2.25%
- Dividend Yield (Forward)
- 2.25%
- Dividend Payment Schedule
- May, Sep
- Total Yield
- 7.41%
Company Profile
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute care hospital and chronic care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Core
- Total Number of Employees
- 10,000
- Website
- https://www.convatecgroup.com
Competitors
Valuation
|
Metric
|
CTEC
|
COLO B
|
BDX
|
|---|---|---|---|
Price/Earnings (Normalized) | 25.34 | 37.31 | 15.30 |
Price/Book Value | 4.46 | 8.17 | 2.22 |
Price/Sales | 2.64 | 3.84 | 2.81 |
Price/Cash Flow | 14.24 | 13.95 | 15.01 |
Price/Earnings
CTEC
COLO B
BDX
Financial Strength
|
Metric
|
CTEC
|
COLO B
|
BDX
|
|---|---|---|---|
Quick Ratio | 1.06 | 0.88 | 0.36 |
Current Ratio | 1.93 | 1.56 | 0.94 |
Interest Coverage | 3.34 | 6.65 | 3.53 |
Quick Ratio
CTEC
COLO B
BDX
Profitability
|
Metric
|
CTEC
|
COLO B
|
BDX
|
|---|---|---|---|
Return on Assets (Normalized) | 9.54% | 11.86% | 4.97% |
Return on Equity (Normalized) | 22.72% | 38.99% | 10.63% |
Return on Invested Capital (Normalized) | 13.15% | 15.76% | 7.26% |
Return on Assets
CTEC
COLO B
BDX
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|?ysTt%jb | LOCK|>m | $160B | |||
| Becton Dickinson & Co
BDX
| LOCK|?M | LOCK|njTd& | $54B | |||
| ResMed Inc
RMD
| LOCK|J@z!R@WS | LOCK|$&hzq | $36B | |||
| Alcon Inc
ALC
| LOCK|rwr@&rh | LOCK|fMY@v | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|@Km>?w | LOCK|ZdvL | $30B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|KKJh#$z? | LOCK|V>K | $28B | |||
| Solventum Corp
SOLV
| LOCK|h$cr$w^ | LOCK|CL | $15B | |||
| Baxter International Inc
BAX
| LOCK|hn | LOCK|W%$j | $13B | |||
| The Cooper Companies Inc
COO
| LOCK|@tDbV#g | LOCK|!yqd! | $12B | |||
| Repligen Corp
RGEN
| LOCK|^zBx%^q | LOCK|yX&J | $11B |
United States